Jacob Small Cap Growth Investor JSCGX

Medalist Rating as of | See Jacob Investment Hub
  • NAV / 1-Day Return 18.69  /  +1.19 %
  • Total Assets 6.9 Mil
  • Adj. Expense Ratio
    3.080%
  • Expense Ratio 3.080%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.00
  • Turnover 64%

USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:20 PM GMT+0

Morningstar’s Analysis JSCGX

Will JSCGX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Jacob Small Cap Growth Investor's Average People Pillar and Process Pillar ratings are n't enough to prevent other weaknesses from sending this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings JSCGX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 49.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Harrow Inc

6.73 457,783
Healthcare

Inspired Entertainment Inc

5.32 362,267
Consumer Cyclical

Cantaloupe Inc

5.00 340,355
Technology

CareDx Inc

4.86 331,053
Healthcare

Doximity Inc Class A

4.85 330,046
Healthcare

Heron Therapeutics Inc

4.65 316,740
Healthcare

Alphatec Holdings Inc

4.62 314,158
Healthcare

Esperion Therapeutics Inc

4.47 304,140
Healthcare

Thunderbird Entertainment Group Inc

4.36 296,700
Communication Services

OptimizeRx Corp

4.35 296,350
Healthcare

Sponsor Center